NHI: financial statements from SEC — TradeAlmanac

NHI

National Health Investors, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	115m	90m	91m	89m	83m	85m
Selling, general and administrative	8m	6m	6m	7m	5m	5m
Operating expenses	78m	58m	56m	56m	55m	52m
Interest expense	15m	14m	15m	14m	15m	15m
Net income	40m	33m	37m	34m	29m	35m
Earnings per share	0.83	0.69	0.79	0.75	0.66	0.81
Earnings per share, diluted	0.82	0.69	0.79	0.74	0.65	0.81
Weighted average shares	48m	47m	47m	46m	43m	43m
Weighted average shares, diluted	49m	48m	47m	46m	44m	44m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	25m	20m	82m	19m	135m	24m	16m	15m
Property, plant and equipment	2.56bn	2.47bn	2.30bn

Cash flow

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	53m	—	—	46m	—	—
Depreciation and amortisation	24m	20m	20m	19m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)